Kanayama M, Izumi Y, Onai N, Akashi T, Hiraoka Y, and Ohteki T. Diverse developmental pathways of lymphoid conventional dendritic cells with distinct tissue distribution and function. Science Advances 11:eadt4909, 2025.
Nakagawa S, Sato T, Ohashi E, Kajita M, Miya F, Yamamoto K, Yotsumata H, Yamaguchi K, Nakajima Y, Miura A, Kinugasa Y, and Ohteki T. An organoid library of human esophageal squamous cell carcinomas (ESCCs) uncovers the chemotherapy-resistant ESCC features. Communications Biology 8:507, 2025.
Sase M, Sato T, Sato H, Miya F, Zhang S, Haeno H, Kajita M, Noguchi T, Mori Y, and Ohteki T. Comparative analysis of tongue cancer organoids among patients identifies the heritable nature of minimal residual disease. Developmental Cell 60:396-413.e6, 2025.
Akiyama M, Kanayama M, Umezawa Y, Nagao T, Izumi Y, Yamamoto M, and Ohteki T. An early regulatory mechanism of hyperinflammation by restricting monocyte contribution. Front Immunol 15:1398153, 2024.
Kamii Y, Hayashizaki K, Kanno T, Chiba A, Ikegami T, Saito M, Akeda Y, Ohteki T, Kubo M, Yoshida K, Kawakami K, Oishi K, Araya J, Kuwano K, Kronenberg M, Endo Y, and Kinjo Y. IL-27 regulates the differentiation of follicular helper NKT cells via metabolic adaptation of mitochondria. Proc Natl Acad Sci USA 121:e2313964121, 2024.
Ohara D, Takeuchi Y, Watanabe H, Lee Y, Mukoyama H, Ohteki T, Kondoh G, and Hirota K. Notch2 with retinoic acid license IL-23 expression by intestinal EpCAM+DCIR2+ cDC2s in mice. J Exp Med 221:e20230923, 2024.
Abe S, Asahi T, Hara T, Cui G, Shimba A, Tani-ichi S, Yamada K, Miyazaki K, Miyachi H, Kitano S, Nakamura N, Kikuta J, Vandenbon A, Miyazaki M, Yamada R, Ohteki T, Ishii M, Sexl V, Nagasawa T, and Ikuta K. Hematopoietic cell-derived IL-15 supports NK cell development in scattered and clustered localization within the bone marrow. Cell Rep 42:113127, 2023.
Ziegler-Heitbrock L, Ohteki T, Ginhoux F, Shortman K, Spits H. Reply to 'Reclassifying plasmacytoid dendritic cells as innate lymphocytes is premature'. Nat Rev Immunol 23:338-339, 2023.